{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:12:24Z","timestamp":1782843144281,"version":"3.54.5"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ30608"],"award-info":[{"award-number":["2021JJ30608"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cca.2022.09.017","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T04:20:11Z","timestamp":1663734011000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Interleukin-38 in atherosclerosis"],"prefix":"10.1016","volume":"536","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-2737","authenticated-orcid":false,"given":"Xiao-Hong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7855","key":"10.1016\/j.cca.2022.09.017_b0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cca.2022.09.017_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/biom8030080","article-title":"Research Progress on the Relationship between Atherosclerosis and Inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.cca.2022.09.017_b0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in Atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2022.09.017_b0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vph.2018.08.002","article-title":"Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease","volume":"112","author":"Maguire","year":"2019","journal-title":"Vasc.Pharmacol."},{"issue":"10","key":"10.1016\/j.cca.2022.09.017_b0025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and Reverse Cholesterol Transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.cca.2022.09.017_b0030","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/0022034520945209","article-title":"IL-1 Superfamily Members and Periodontal Diseases","volume":"99","author":"Papathanasiou","year":"2020","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.cca.2022.09.017_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2013.00167","article-title":"New Insights in the Immunobiology of IL-1 Family Members","volume":"4","author":"van de Veerdonk","year":"2013","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2022.09.017_b0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41423-019-0300-7","article-title":"Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma","volume":"17","author":"Sun","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2022.09.017_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107528","article-title":"Biology of interleukin-38 and its role in chronic inflammatory diseases","volume":"95","author":"Xia","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cca.2022.09.017_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155824","article-title":"Interleukin-38 in Health and Disease","volume":"152","author":"de Graaf","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2022.09.017_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155334","article-title":"Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease","volume":"137","author":"de Graaf","year":"2021","journal-title":"Cytokine"},{"issue":"21","key":"10.1016\/j.cca.2022.09.017_b0060","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.1111\/jcmm.15737","article-title":"IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis","volume":"24","author":"Xu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.cca.2022.09.017_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106592","article-title":"IL-38 alleviates the inflammatory response and the degeneration of nucleus pulposus cells via inhibition of the NF-kappaB signaling pathway in vitro","volume":"85","author":"Yu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cca.2022.09.017_b0070","doi-asserted-by":"crossref","unstructured":"B. Pei, K. Chen, S. Zhou, D. Min, W. Xiao, IL-38 restrains inflammatory response of collagen-induced arthritis in rats via SIRT1\/HIF-1alpha signaling pathway, Biosci Rep 40(5) (2020) BSR20182431.","DOI":"10.1042\/BSR20182431"},{"issue":"11","key":"10.1016\/j.cca.2022.09.017_b0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","article-title":"IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment","volume":"9","author":"Mercurio","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2022.09.017_b0080","first-page":"386","article-title":"IL-38: A new factor in rheumatoid arthritis","volume":"4","author":"Takenaka","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"issue":"7","key":"10.1016\/j.cca.2022.09.017_b0085","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/annrheumdis-2016-210630","article-title":"IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro","volume":"76","author":"Boutet","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2022.09.017_b0090","doi-asserted-by":"crossref","unstructured":"Y. Zhong, K. Yu, X. Wang, X. Wang, Q. Ji, Q. Zeng, Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment, Mediators Inflamm 2015 (2015) 490120.","DOI":"10.1155\/2015\/490120"},{"issue":"11","key":"10.1016\/j.cca.2022.09.017_b0095","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/107999001753289505","article-title":"Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14","volume":"21","author":"Bensen","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"issue":"23","key":"10.1016\/j.cca.2022.09.017_b0100","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1074\/jbc.M010095200","article-title":"Cloning and characterization of IL-1HY2, a novel interleukin-1 family member","volume":"276","author":"Lin","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.cca.2022.09.017_b0105","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.cca.2022.09.017_b0110","doi-asserted-by":"crossref","first-page":"16475","DOI":"10.1073\/pnas.2004666117","article-title":"IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder","volume":"117","author":"Tsilioni","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.cca.2022.09.017_b0115","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","article-title":"Identification and initial characterization of four novel members of the interleukin-1 family","volume":"275","author":"Kumar","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.cca.2022.09.017_b0120","doi-asserted-by":"crossref","first-page":"12552","DOI":"10.3390\/ijms222212552","article-title":"Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study","volume":"22","author":"Esmaeilzadeh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00441-021-03495-8","article-title":"Compartmentalization of interleukin 36 subfamily according to inducible and constitutive expression in the kidneys of a murine autoimmune nephritis model","volume":"386","author":"Namba","year":"2021","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.cca.2022.09.017_b0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1159\/000493029","article-title":"Elevated Interleukin-38 Level Associates with Clinical Response to Atorvastatin in Patients with Hyperlipidemia","volume":"49","author":"Yang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.cca.2022.09.017_b0135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/eji.201948390","article-title":"Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects","volume":"51","author":"de Graaf","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cca.2022.09.017_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108315","article-title":"IL-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates Th17 differentiation in vivo","volume":"210","author":"Chai","year":"2020","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12985-021-01687-w","article-title":"Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice","volume":"18","author":"Xue","year":"2021","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.14741","article-title":"Interleukin-38 alleviates cardiac remodelling after myocardial infarction","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jmcb\/mjw006","article-title":"Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses","volume":"8","author":"Mora","year":"2016","journal-title":"J. Mol. Cell. Biol."},{"issue":"8","key":"10.1016\/j.cca.2022.09.017_b0160","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.cca.2022.09.017_b0165","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00018-018-2983-9","article-title":"Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis","volume":"76","author":"Paone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.cca.2022.09.017_b0170","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.medcli.2020.04.024","article-title":"Atherosclerosis and inflammation. New therapeutic approaches","volume":"155","author":"Pedro-Botet","year":"2020","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.hfc.2012.06.014","article-title":"Insulin resistance and atherosclerosis","volume":"8","author":"Raghavan","year":"2012","journal-title":"Heart Fail Clin"},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.2518","article-title":"Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis","volume":"218","author":"Sluimer","year":"2009","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.cca.2022.09.017_b0185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2022.09.017_b0190","doi-asserted-by":"crossref","unstructured":"S. Philip, T. Ponnusamy, L.N. Rao, S. Biradar, R. Kumar, V. Deshpande, X. Lu, V.V. Kakkar, L.A. Mundkur, Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits, Can J Cardiol 32(8) (2016) 1008 e1-1008 e10.","DOI":"10.1016\/j.cjca.2015.09.022"},{"issue":"8","key":"10.1016\/j.cca.2022.09.017_b0195","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2174\/1381612822666161230142931","article-title":"Inflammation: A Novel Therapeutic Target\/Direction in Atherosclerosis","volume":"23","author":"Li","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.cca.2022.09.017_b0200","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jacc.2019.07.061","article-title":"From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week","volume":"74","author":"Libby","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2022.09.017_b0205","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/cvr\/cvz107","article-title":"Immunometabolism orchestrates training of innate immunity in atherosclerosis","volume":"115","author":"van Tuijl","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.cca.2022.09.017_b0210","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","article-title":"Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis","volume":"144","author":"Edgar","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cca.2022.09.017_b0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MOL.0000000000000023","article-title":"Trained innate immunity and atherosclerosis","volume":"24","author":"Bekkering","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.cca.2022.09.017_b0220","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gistera","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.cca.2022.09.017_b0230","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","article-title":"Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice","volume":"117","author":"Combadiere","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/138945006775270240","article-title":"Chemokines as potential therapeutic targets in atherosclerosis","volume":"7","author":"Sheikine","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"17","key":"10.1016\/j.cca.2022.09.017_b0240","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1007\/s00018-015-1925-z","article-title":"Chemokines and microRNAs in atherosclerosis","volume":"72","author":"Hartmann","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.cca.2022.09.017_b0245","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/art.39328","article-title":"Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus","volume":"67","author":"Rudloff","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3164\/jcbn.21-104","article-title":"The anti-inflammatory and protective role of interleukin-38 in inflammatory bowel disease","volume":"70","author":"Ohno","year":"2022","journal-title":"J Clin Biochem Nutr"},{"issue":"7","key":"10.1016\/j.cca.2022.09.017_b0255","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/infdis\/jiy289","article-title":"Interleukin 38 Protects Against Lethal Sepsis","volume":"218","author":"Xu","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cca.2022.09.017_b0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"13","key":"10.1016\/j.cca.2022.09.017_b0265","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.cca.2022.09.017_b0270","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cca.2022.09.017_b0275","doi-asserted-by":"crossref","first-page":"6370911","DOI":"10.1155\/2021\/6370911","article-title":"IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome","volume":"2021","author":"Ge","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"8","key":"10.1016\/j.cca.2022.09.017_b0280","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.cca.2022.09.017_b0285","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.117.312513","article-title":"Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry","volume":"122","author":"Winkels","year":"2018","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0290","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/ATVBAHA.114.303566","article-title":"Dendritic cells in atherosclerosis: evidence in mice and humans","volume":"35","author":"Zernecke","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2022.09.017_b0295","doi-asserted-by":"crossref","unstructured":"M. Chu, I.M. Chu, E.C. Yung, C.W. Lam, T.F. Leung, G.W. Wong, C.K. Wong, Aberrant Expression of Novel Cytokine IL-38 and Regulatory T Lymphocytes in Childhood Asthma, Molecules (Basel, Switzerland) 21(7) (2016) 933.","DOI":"10.3390\/molecules21070933"},{"issue":"11","key":"10.1016\/j.cca.2022.09.017_b0300","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.it.2011.07.001","article-title":"How dendritic cells shape atherosclerosis","volume":"32","author":"Koltsova","year":"2011","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.cca.2022.09.017_b0305","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jcmm.12923","article-title":"Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-alpha mediated NF-kappaB pathway","volume":"20","author":"Gao","year":"2016","journal-title":"J. Cell Mol. Med."},{"issue":"6284","key":"10.1016\/j.cca.2022.09.017_b0310","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0315","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCRESAHA.117.312465","article-title":"Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis","volume":"122","author":"Leentjens","year":"2018","journal-title":"Circ. Res."},{"issue":"6204","key":"10.1016\/j.cca.2022.09.017_b0320","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0325","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/JLB.3A0220-143RRR","article-title":"IL-38 prevents induction of trained immunity by inhibition of mTOR signaling","volume":"110","author":"de Graaf","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.cca.2022.09.017_b0330","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"10","key":"10.1016\/j.cca.2022.09.017_b0335","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0340","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/intimm\/dxv068","article-title":"CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas","volume":"28","author":"Butcher","year":"2016","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0345","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacbts.2017.08.005","article-title":"Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A","volume":"3","author":"Nordlohne","year":"2018","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"10.1016\/j.cca.2022.09.017_b0350","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2022.09.017_b0355","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molimm.2020.09.006","article-title":"Blockade of Th17 response by IL-38 in primary Sjogren's syndrome","volume":"127","author":"Luo","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cca.2022.09.017_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.732790","article-title":"The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases","volume":"12","author":"Han","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cca.2022.09.017_b0365","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.imbio.2016.10.012","article-title":"In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)\/lpr mice","volume":"222","author":"Chu","year":"2017","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0370","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2017.09.014","article-title":"The Burgeoning World of Immunometabolites: Th17 Cells Take Center Stage","volume":"26","author":"Bantug","year":"2017","journal-title":"Cell Metab."},{"issue":"7829","key":"10.1016\/j.cca.2022.09.017_b0375","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","article-title":"A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis","volume":"586","author":"Zhang","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cca.2022.09.017_b0380","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.cca.2022.09.017_b0385","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.62.15.31","article-title":"Therapeutic Effect of IL-38 on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Cell Pathogenicity","volume":"62","author":"Li","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cca.2022.09.017_b0390","article-title":"Treg: A Promising Immunotherapeutic Target in Oral Diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0395","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1007\/s11033-021-06483-x","article-title":"Treg cells in atherosclerosis","volume":"48","author":"Kuan","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cca.2022.09.017_b0400","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yjmcc.2019.05.009","article-title":"Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice","volume":"132","author":"Vila-Caballer","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"21","key":"10.1016\/j.cca.2022.09.017_b0405","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/eurheartj\/ehl284","article-title":"Lymphocyte responses in acute coronary syndromes: lack of regulation spawns deviant behaviour","volume":"27","author":"Caligiuri","year":"2006","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.cca.2022.09.017_b0410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0415","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00018-015-2080-2","article-title":"Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential","volume":"73","author":"Spitz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"17","key":"10.1016\/j.cca.2022.09.017_b0420","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/eurheartj\/eht543","article-title":"Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes","volume":"36","author":"Klingenberg","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.cca.2022.09.017_b0425","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/jcmm.14902","article-title":"Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4(+) CD25(+) regulatory T cells","volume":"24","author":"Ge","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"24","key":"10.1016\/j.cca.2022.09.017_b0430","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa035655","article-title":"Intraplaque hemorrhage and progression of coronary atheroma","volume":"349","author":"Kolodgie","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cca.2022.09.017_b0435","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","article-title":"Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage","volume":"25","author":"Virmani","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2022.09.017_b0440","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camare","year":"2017","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0445","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/s41598-017-03079-z","article-title":"The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0450","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"issue":"8","key":"10.1016\/j.cca.2022.09.017_b0455","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/1566524019666190627122655","article-title":"The Effect of Interleukin 38 on Inflammation-induced Corneal Neovascularization","volume":"19","author":"Zhu","year":"2019","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.cca.2022.09.017_b0460","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1038\/srep16053","article-title":"Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3\/GIV signaling pathway in non-small-cell lung cancer","volume":"5","author":"Pan","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0465","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular Smooth Muscle Cells in Atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2022.09.017_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105599","article-title":"Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis","volume":"168","author":"Duan","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0475","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MOL.0b013e328357a379","article-title":"Macrophage proliferation and apoptosis in atherosclerosis","volume":"23","author":"Andres","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2022.09.017_b0480","doi-asserted-by":"crossref","unstructured":"A. Pena-Blanco, A.J. Garcia-Saez, Bax, Bak and beyond - mitochondrial performance in apoptosis, FEBS J 285(3) (2018) 416-431.","DOI":"10.1111\/febs.14186"},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0485","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/biom10010128","article-title":"The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms","volume":"10","author":"Banjara","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2022.09.017_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107489","article-title":"The elevated expression of IL-38 serves as an anti-inflammatory factor in osteoarthritis and its protective effect in osteoarthritic chondrocytes","volume":"94","author":"Jiang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cca.2022.09.017_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2019.113735","article-title":"Acrolein-induced apoptosis of smooth muscle cells through NEAT1-Bmal1\/Clock pathway and a protection from asparagus extract","volume":"258","author":"Chen","year":"2020","journal-title":"Environ. Pollut."},{"issue":"1\u20132","key":"10.1016\/j.cca.2022.09.017_b0500","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cccn.2003.11.009","article-title":"Nitric oxide-induced apoptosis is mediated by Bax\/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells","volume":"341","author":"Chae","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2022.09.017_b0505","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbi.2016.08.013","article-title":"Role of Cyt-C\/caspases-9,3, Bax\/Bcl-2 and the FAS death receptor pathway in apoptosis induced by zinc oxide nanoparticles in human aortic endothelial cells and the protective effect by alpha-lipoic acid","volume":"258","author":"Liang","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0510","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cmet.2009.03.003","article-title":"Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-\/- and Ldlr-\/- mice lacking CHOP","volume":"9","author":"Thorp","year":"2009","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.cca.2022.09.017_b0515","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0520","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and metabolic health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cca.2022.09.017_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109735","article-title":"Suppression of GATA-3 increases adipogenesis, reduces inflammation and improves insulin sensitivity in 3T3L-1 preadipocytes","volume":"75","author":"Al-Mansoori","year":"2020","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.cca.2022.09.017_b0530","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/cbin.11428","article-title":"Interleukin-38 inhibits adipogenesis and inflammatory cytokine production in 3T3-L1 preadipocytes","volume":"44","author":"Li","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.cca.2022.09.017_b0535","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2018.11.114","article-title":"Hydrodynamic delivery of IL-38 gene alleviates obesity-induced inflammation and insulin resistance","volume":"508","author":"Xu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cca.2022.09.017_b0540","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MOL.0000000000000540","article-title":"Lipid-driven immunometabolic responses in atherosclerosis","volume":"29","author":"Gistera","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.cca.2022.09.017_b0545","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2337\/dc07-1540","article-title":"Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance","volume":"31","author":"Caballero","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2022.09.017_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106264","article-title":"Interleukin-38 increases the insulin sensitivity in children with the type 2 diabetes","volume":"82","author":"Liu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0555","doi-asserted-by":"crossref","first-page":"E771","DOI":"10.1152\/ajpendo.00560.2005","article-title":"Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes","volume":"291","author":"Tsuchiya","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.cca.2022.09.017_b0560","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cmet.2011.02.010","article-title":"Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway","volume":"13","author":"Awazawa","year":"2011","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.cca.2022.09.017_b0565","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/db14-1098","article-title":"Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1beta secretion and insulin resistance despite obesity","volume":"64","author":"Finucane","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2022.09.017_b0570","doi-asserted-by":"crossref","unstructured":"Y. Han, J. Mora, A. Huard, P. da Silva, S. Wiechmann, M. Putyrski, C. Schuster, E. Elwakeel, G. Lang, A. Scholz, T. Scholz, T. Schmid, N. de Bruin, P. Billuart, C. Sala, H. Burkhardt, M.J. Parnham, A. Ernst, B. Brune, A. Weigert, IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from gammadelta T Cells, Cell Rep 27(3) (2019) 835-846 e5.","DOI":"10.1016\/j.celrep.2019.03.082"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122013158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122013158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:06:02Z","timestamp":1757862362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122013158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":114,"alternative-id":["S0009898122013158"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.09.017","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-38 in atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}